EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NYSE Amex: AIS), a leader in self injection drug delivery technology, today announced the receipt of a milestone payment from Ferring International Center S.A. The payment was related to achieving a development-based milestone under the license and asset purchase agreements announced in November 2009 regarding certain intellectual property relating to transdermal gel delivery technology. The amount of the milestone payment was not disclosed.
